Effect of Constituents from Fructus Aurantii Immaturus and Radix Paeoniae Alba on Gastrointestinal Movement

Abstract

Fructus Aurantii Immaturus and Radix Paeoniae Alba Powder (FPP) is a popular Chinese herbal prescription. The combination of Fructus Aurantii Immaturus and Radix Paeoniae Alba has been used to treat gastrointestinal disorders for hundreds of years. To our interest, this combination shows a bilateral effect on gastrointestinal peristalsis. Our present study was focused on the bilateral role of this combination on the gastrointestinal tract. The effective constituents and mechanisms were explored. Six monomer constituents from Radix Paeoniae Alba and Fructus Aurantii Immaturus were screened by intestinal transit assay. The bilateral roles of three effective constituents were authenticated by gastric emptying assay, and the combination of three constituents showed a bilateral effect. Then, the mediating receptors and the role of NO and NF-κB p65 were examined to determine the mechanism involved. The overall results suggest that the major effective constituents of this combination are synephrine, hesperidin and paeoniflorin. Synephrine inhibits the gastrointestinal movement, while hesperidin stimulates it. Paeoniflorin shows different effects on intestinal and gastric activity. The effect of synephrine relies on the α-adrenergic receptor, and the effect of hesperidin is mediated via the H1 histamine receptor. The regulation of hesperidin and synephrine on NF-κB p65 translocation and NO production through the α-receptor and the H1 receptor, respectively, is involved in the bilateral effect of the Fructus Aurantii Immaturus-Radix Paeoniae Alba combination.

Citrus aurantium L. - Rutaceae - Paeonia lactiflora Pall - Paeoniaceae - gastrointestinal movement

References

• 1 Zhang L, Sun Y, Chen T, Xu Q. Selective depletion of glycyrrhizin from Si-Ni-San, a traditional Chinese prescription, blocks its effect on contact sensitivity in mice and recovers adhesion and metalloproteinases production of T lymphocytes.  Int Immunopharmacol. 2005;  5 1193-204
• 2 Ohta Y, Kobayashi T, Hayashi T, Inui K, Yoshino J, Nakazawa S. Preventive effect of Shigyaku-san on progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.  Phytother Res. 2006;  20 256-62
• 3 Zhang Q R, Zhu K G, Peng J X, Li L. Effect of Fructus Aurantii Immaturus decoction on rabbit intestinal smooth muscle.  Chin J Tradit Med Sci Technol. 2006;  13 335-6
• 4 Zhu J Z, Zhang Z J, Zhang J. Effect of immature bitter orange on gastric emptying in rats with functional dyspepsia.  Chin J Clin Pharmacol. 2005;  14 91-4
• 5 Puig M M, Pol O. Peripheral effect of opioids in a model of chronic intestinal inflammation in mice.  J Pharmacol Exp Ther. 1998;  287 1068-75
• 6 Jia Q, Bai Y, Ma Y, Peng W, Su W W. HPLC-ESI-MS analysis of chemical constituents in ZhiQiao and Fructus Aurantii Immaturus.  Chin Tradit Herb Drugs. 2005;  36 169-72
• 7 Gharzouli K, Gharzouli A, Amira S. Protective effect of mannitol, glucose-fructose-sucrose-maltose mixture, and natural honey hyperosmolar solutions against ethanolinduced ethanolinduced gastric mucosal damage in rats.  Exp Toxicol Pathol. 2001;  53 175-80
• 8 Wei D Z, Mei Y Y, Liu J W. Quantification of doxorubicin and validation of reversal effect of tea polyphenols on multidrug resistance in human carcinoma cells.  Biotechnol Lett. 2003;  25 291-4
• 9 Garg A, Garg S, Zaneveld L JD, Singla A K. Chemistry and pharmacology of the Citrus bioflavonoid hesperidin.  Phytother Res. 2001;  15 655-69
• 10 Guan F L. The effect of hesperidin and synephrine on the isolated gastric smooth muscle cells.  Chin Pharmacol Bull. 2004;  20 1420-5
• 11 Yang X J, Li J J, Kyoshi N, Wei M X. Study on mechanism of TGP acting on colon smooth muscle of guinea pig.  Chin J Int Trad West Med Dig. 2002;  10 151-3
• 12 Tsai H Y, Lin Y T, Chen C F, Tsai C H, Chen Y F. Effect of veratrine and paeoniflorin on the isolated rat aorta.  J Ethnopharmacol. 1999;  66 249-55
• 13 Kim S H, Zo J H, Kim M A, Hwang K K, Chae I H, Kim H S. et al . Naringin suppresses the mitogenic effect of lysophosphatidylcholine on vascular smooth muscle cells.  Nutr Res. 2003;  23 1671-83
• 14 Touvay C, Vilain B, Carre C, Mencia-Huerta J M, Braquet P. Effect of limonene and sobrerol on monocrotaline-induced lung alterations and pulmonary hypertension.  Int Arch Allergy Immunonol. 1995;  107 272-4
• 15 Liu L J, Wei Y Q, Xu Q Y, Yang D Z. The regulation of histamine receptor antagonist in the effect of Fructus Aurantii Immaturus on the motor activity of small intestine in mice.  J Southeast Univ Med Sci Ed. 2001;  20 144-6
• 16 Shah V, Lyford G, Gores G, Farrugia G. Nitric oxide in gastrointestinal health and disease.  Gastroenterology. 2004;  126 903-13
• 17 Schini V B, Busse R, Vanhoutte P M. Inducible nitric synthethase in vascular smooth muscle.  Arzneimittelforschung. 1994;  44 432-35
• 18 Bartho L, Lefebvre R A. Nitric oxide-mediated contraction in enteric smooth muscle.  Arch Int Pharm Ther. 1995;  329 53-66
• 19 Martin M J, Jimenez M D, Motilva V. New issues about nitric oxide and its effect on gastrointestinal tract.  Curr Pharm Design. 2001;  7 881-908
• 20 Hodges R R, Shatos M A, Tarko R S, Vrouvlianis J, Gu J, Dartt D A. Nitric oxide and cGMP mediated α1-adrenegic receptor stimulated protein secration and p42/p44 MAPK activation in rat lacrimal gland.  Invest Ophthal Visc Sci. 2005;  46 2781-9
• 21 Oscar G, Carlos B, Francisco J L, Porfirio G, Madai A G, Kurt H. et al . Facilitation of estrous behavior by vaginal cervical stimulation in female rats involves α1-adrenergic receptor activation of the nitric oxide pathway.  Behav Brain Res. 2007;  176 237-43
• 22 Enri B, Graciela S, Leonor S. H1-Receptor activation triggers the endogenous nitric oxide signaling system in the rat submandibular gland.  Mediat Inflamm. 2002;  11 337-43
• 23 Mariana L, Gary M. The histamine H1 receptor activates the nitric oxide pathway at fertilization.  Mol Reprod Dev. 2006;  73 1550-63
• 24 Cho C H. Current roles of nitric oxide in gastrointestinal disorders.  J Physiol Paris. 2001;  95 253-6
• 25 Brasier A R. The NF-kappaB regulatory network.  Cardiovasc Toxicol. 2006;  6 111-30
• 26 Xie Q W, Yuki K, Carl N. Role of transcription factor NF-κB /Rel in induction of nitric oxide synthase.  J Biol Chem. 1994;  269 4705-8
• 27 Ma X L, Li Y H, Gao J X, Li J, Guo L, Wu C Z. Expression of inducible nitric oxide synthase in the liver is under the control of nuclear factor kappa B in concanavalin A-induced hepatitis. J Gastroenterol Hepatol 2007: doi:10.1111/j.1440 – 1746.2007.05083.x
• 28 Ko H C, Kuo Y H, Wei B L, Chiou W F. Laxifolone A suppresses LPS/IFN-gamma-induced NO synthesis by attenuating NF-kappaB translocation: role of NF-kappaB p105 level.  Planta Med. 2005;  71 514-9
• 29 Meldrum D R, Cleveland J C, Sheridan B C, Rowland R T, Selzman C H, Banerjee A. et al . Alpha-adrenergic activation of myocardial NF kappa B during hemorrhage.  J Surg Res. 1997;  69 268-76
• 30 Tanimoto A, Wang K Y, Murata Y, Kimura S, Nomaquchi M, Nakata S. et al . Histamine upregulates the expression of inducible nitric oxide synthase in human intimal smooth muscle cells via histamine H1 receptor and NF-kappaB signaling pathway.  Arterioscl Thromb Vasc. 2007;  27 1556-61